Le Lézard
Classified in: Health, Science and technology, Business
Subject: ECO

Bionomics Limited (Nasdaq: BNOX, ASX: BNO) to Ring the Nasdaq Stock Market Closing Bell on Friday January 14, 2022


EASTWOOD, Australia, Jan. 14, 2022 /PRNewswire/ -- Bionomics Limited (Nasdaq: BNOX, ASX: BNO), a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders with high unmet medical need, will ring the Nasdaq Closing Bell remotely from around the globe.

Dr Errol De Souza, Executive Chairman, will ring the Closing Bell alongside the Company's team in a virtual bell ringing ceremony.

When:
FRIDAY, JANUARY 14, 2021 ? 3:45 p.m. to 4:00 p.m. ET 

Webcast:
A live stream of the Nasdaq Closing Bell will be available at: https://www.nasdaq.com/marketsite/bell-ringing-ceremony  

Social Media:
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please visit our Facebook page: http://www.facebook.com/nasdaq

For photos from ceremonies and events, please visit our Instagram page: http://instagram.com/nasdaq

Photos:
To obtain a hi-resolution photograph of the Market Close, please go to https://www.nasdaq.com/marketsite/bell-ringing-ceremony  and click on the market close of your choice.

FOR FURTHER INFORMATION PLEASE CONTACT:

General:

Ms Suzanne Irwin

Company Secretary

+61 8 8150 7400

[email protected] 

Investor Relations:

Mr. Connor Bernstein

Vice President, Strategy and Corporate Development

+1 (831) 246 3642

[email protected]

About Bionomics Limited:
Bionomics (Nasdaq: BNOX, ASX:BNO) is a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders with high unmet medical need. Bionomics is advancing its lead product candidate, BNC210, an oral, proprietary, selective negative allosteric modulator of the ?7 nicotinic acetylcholine receptor, for the acute treatment of Social Anxiety Disorder and chronic treatment of Post-Traumatic Stress Disorder. Beyond BNC210, Bionomics has a strategic partnership with Merck & Co., Inc. (known as MSD outside the United States and Canada) with two drugs in early-stage clinical trials for the treatment of cognitive deficits in Alzheimer's disease and other central nervous system conditions.  To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Twitter @Bionomics1, or at www.bionomics.com.au.

About Nasdaq:
Nasdaq (Nasdaq: NDAQ) is a global technology company serving the capital markets and other industries. Our diverse offering of data, analytics, software and services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at www.nasdaq.com.

SOURCE Bionomics Limited


These press releases may also interest you

at 09:28
IDTechEx Research, a trusted provider of independent market intelligence, announces the availability of a new report, "Thermal Energy Storage 2024-2034: Technologies, Players, Markets, and Forecasts"....

at 09:27
Serum Detect, a cancer diagnostics company, is debuting a novel and promising approach for cancer early detection at the...

at 09:25
Veeam® Software, the #1 leader by market share in Data Protection and Ransomware Recovery, today announced that the City of Fort Lauderdale, Florida, has deployed Veeam Data Platform and Veeam Backup for Microsoft 365 to enable high-speed recovery of...

at 09:25
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the 2023 annual results as of 31 December 2023. Financial Highlights Revenue increased by 18.1% to...

at 09:25
To help prepare nursing students for real-world practice, Wolters Kluwer Health today announces the launch of Lippincott Ready for NCLEX®, a complete test prep solution for the National Council Licensure Examination (NCLEX). The new product marks the...

at 09:22
A unique online platform, My Yoga Journey, has been launched by Yourself Yoga for Menopause to provide yoga exclusively for women in menopause who prefer a natural solution to help alleviate their symptoms....



News published on and distributed by: